Phase 4 Colorectal Cancer Trial, Recruiting NCT05148494 Sponsor: Nova Scotia Health Authority Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 4 Colorectal Cancer Trial, Recruiting

NCT05148494
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have a type of keyhole surgery performed through the back passage (called transanal endoscopic surgery) at the QEII Health Sciences Center in Halifax, carried out by one of their specialist bowel surgeons

Who may not be able to join:

  • People who have ongoing, hard-to-control constipation that does not improve with dietary changes or stool softeners
  • People who have previously had radiation treatment to the pelvic area
  • People who have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • People who are having this type of surgery again on the same area that was treated before
  • People who are not able to self-administer enemas (a liquid inserted into the back passage to clear the bowel)
  • People who are unable to tolerate either of the two bowel preparation methods used in this trial due to health reasons
  • People aged over 75
  • People with a confirmed diagnosis of congestive heart failure (a condition where the heart does not pump blood as well as it should)
  • People who take a water tablet called Lasix (furosemide) or a similar medication (known as a loop diuretic) every day
  • People who take steroid medication on a long-term, ongoing basis
  • People whose transanal endoscopic surgery is being combined with another surgical procedure at the same time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Katerina Neumann, NSHA

Phone: 902 473 3937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Nova Scotia Health Authority
Registry
ClinicalTrials.gov
Start date
16 March 2022
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Quality of bowel preparation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov